Colinz Laboratories Intrinsic Value
Colinz Laboratories (COLINZ) median intrinsic value is ₹133.33 from 9 valuation models (range ₹32–₹239), vs current price ₹79.75 — +67.2% upside (Trading Below Calculated Value), margin of safety 40.2%. For current market price and key ratios, visit Colinz Laboratories share price today.
COLINZ Valuation Methods Summary — DCF, Graham Number & P/E
Colinz Laboratories intrinsic value across 9 models vs current price ₹79.75 — upside/downside and value range per method. Analyse Colinz Laboratories ownership structure to track promoter, FII and institutional holdings.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹239.25 | ₹191.40 - ₹287.10 | +200.0% | EPS: ₹11.10, Sector P/E: 22x |
| Book Value Method | asset | ₹66.67 | ₹60.00 - ₹73.34 | -16.4% | Book Value/Share: ₹33.33, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹60.00 | ₹54.00 - ₹66.00 | -24.8% | Revenue/Share: ₹30.00, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹133.33 | ₹120.00 - ₹146.66 | +67.2% | EBITDA: ₹4.00Cr, EV/EBITDA: 10x |
| Simple DCF (5Y) | dcf | ₹31.90 | ₹25.52 - ₹38.28 | -60.0% | CF Growth: 5.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹177.60 | ₹159.84 - ₹195.36 | +122.7% | EPS Growth: 20.0%, Fair P/E: 16.0x |
| Growth Adjusted P/E | growth | ₹171.90 | ₹154.71 - ₹189.09 | +115.5% | Revenue Growth: 6.5%, Adj P/E: 15.5x |
| ROE Based Valuation | profitability | ₹159.50 | ₹143.55 - ₹175.45 | +100.0% | ROE: 30.0%, P/E Multiple: 16x |
| Graham Defensive Method | conservative | ₹66.67 | ₹60.00 - ₹73.34 | -16.4% | EPS: ₹11.10, BVPS: ₹33.33 |
COLINZ Intrinsic Value vs Market Price — All Valuation Models
Colinz Laboratories fair value range ₹32–₹239 vs current market price ₹79.75 across 9 valuation models. Read COLINZ dividend track record for the complete payout history and dividend yield track record.
COLINZ Intrinsic Value Analysis — Undervalued or Overvalued?
Colinz Laboratories median intrinsic value ₹133.33, current price ₹79.75 — Trading Below Calculated Value by 67.2%, margin of safety 40.2%.
What is the intrinsic value of COLINZ?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Colinz Laboratories (COLINZ) is ₹133.33 (median value). With the current market price of ₹79.75, this represents a +67.2% variance from our estimated fair value.
The valuation range spans from ₹31.90 to ₹239.25, indicating ₹31.90 - ₹239.25.
Is COLINZ undervalued or overvalued?
Based on our multi-method analysis, Colinz Laboratories (COLINZ) appears to be trading below calculated value by approximately 67.2%.
COLINZ Financial Health — Key Ratios vs Industry Benchmarks
Colinz Laboratories financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Return on Equity | 30.0% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 6.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.69x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
COLINZ Cash Flow Quality — Operating & Free Cash Flow
Colinz Laboratories operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹-2 Cr | ₹-2 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹1 Cr | ₹1 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹1 Cr | ₹1 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹2 Cr | ₹2 Cr | Positive Free Cash Flow | 8/10 |